Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- REASSURE2Independent statistical analysis of Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rebif® Pregnancy Registry: Complete Statistical AnalysisIndependent statistical analysis of Rebif® Pregnancy Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338741).
- RECAD-AFIndependent statistical analysis of Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Recall by Genotype: Neuropeptide Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Recall by Genotype: Neuropeptide Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05901467).
- RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: Complete Statistical AnalysisIndependent statistical analysis of RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ReCePIIndependent statistical analysis of Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- RECIAIndependent statistical analysis of Multifactorial Approach to Emergent Cerclage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114516).
- RECLAIIMIndependent statistical analysis of A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ReCLAIM-2Independent statistical analysis of ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent: Complete Statistical AnalysisIndependent statistical analysis of Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent:…
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475: Complete Statistical AnalysisIndependent statistical analysis of Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03049618).
- Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01928030).
- Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer: primary endpoint results, effect…
- RECORD-4Independent statistical analysis of Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491672).
- RECORGENIndependent statistical analysis of Patients With Chronic Knee Pain Treated With Conventional Radiofrequency of the Genicular Nerves: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RECOVERIndependent statistical analysis of Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00474058).
- RECOVER-AUTONOMIC Platform Protocol: Complete Statistical AnalysisIndependent statistical analysis of RECOVER-AUTONOMIC Platform Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06305780).
- Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR: Complete Statistical AnalysisIndependent statistical analysis of Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rectal Spacer for Prostate Cancer Radiation Image Guidance: Complete Statistical AnalysisIndependent statistical analysis of Rectal Spacer for Prostate Cancer Radiation Image Guidance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650021).
- Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: Complete Statistical AnalysisIndependent statistical analysis of Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: Complete Statistical AnalysisIndependent statistical analysis of Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545181).
- RECYCLINEIndependent statistical analysis of Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Red and Processed Meat Effects on the Metabolome and Microbiome: Complete Statistical AnalysisIndependent statistical analysis of Red and Processed Meat Effects on the Metabolome and Microbiome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05274906).
- Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Red Cell Storage Duration and Outcomes in Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Red Cell Storage Duration and Outcomes in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00458783).
- Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients: Complete Statistical AnalysisIndependent statistical analysis of Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03779984).
- REDEEM-1Independent statistical analysis of BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- REDEFINEIndependent statistical analysis of Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDIRECTIndependent statistical analysis of Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REDNIVINIndependent statistical analysis of Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REDOIndependent statistical analysis of Medtronic CoreValve REDO Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01051310).
- REDPINEIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect…
- REDUCIndependent statistical analysis of Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REDUCE-BPIndependent statistical analysis of Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: primary endpoint results, effect estimate with confidence…
- Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting: primary endpoint results, effect estimate with…
- Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: primary endpoint results, effect estimate with confidence…
- Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc): Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: primary endpoint results, effect…
- Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REDUCEhfIndependent statistical analysis of Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ReducerIndependent statistical analysis of Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…